Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Cirrhosis Portal”

817 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 817 results

Testing effectiveness (Phase 2)Study completedNCT00180674
What this trial is testing

Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection

Who this might be right for
Liver Fibrosis
Imperial College London 14
Not applicableStudy completedNCT04675775
What this trial is testing

The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy.

Who this might be right for
CirrhosisAscitesLiver Diseases+3 more
University of Michigan 17
Not applicableStudy completedNCT00059267
What this trial is testing

Prevention of Recurrent Hepatitis B After Liver Transplantation

Who this might be right for
Hepatitis BCirrhosisAcute Liver Failure+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 317
Large-scale testing (Phase 3)UnknownNCT01134692
What this trial is testing

Probiotics for Portal Hypertension

Who this might be right for
CirrhosisVarices, Esophageal
Govind Ballabh Pant Hospital
Not applicableStudy completedNCT01598064
What this trial is testing

Probiotics for Liver Cirrhosis With Portal Hypertension

Who this might be right for
Liver CirrhosisPortal Hypertension
Po-Lin Chen, MD 49
Large-scale testing (Phase 3)Active Not RecruitingNCT03900429
What this trial is testing

Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Madrigal Pharmaceuticals, Inc. 1,759
Not applicableStudy completedNCT03513900
What this trial is testing

Non-invasive Methods to Predict PHG in Cirrhosis

Who this might be right for
Cirrhosis
Second Affiliated Hospital of Xi'an Jiaotong University 115
Not applicableNot Yet RecruitingNCT07797101
What this trial is testing

Body-weight Reduction Effect on Portal Hypertension in Compensated Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionFatty Liver Disease+1 more
The Second Affiliated Hospital of Chongqing Medical University 50
Testing effectiveness (Phase 2)Study completedNCT01966419
What this trial is testing

Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)

Who this might be right for
Acute Episode of Overt Hepatic EncephalopathyHepatic Encephalopathy
Ocera Therapeutics, Inc. 231
Not applicableStudy completedNCT03201367
What this trial is testing

Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV

Who this might be right for
Portal Vein Thrombosis
Zagazig University 40
Post-approval studies (Phase 4)UnknownNCT02385422
What this trial is testing

The Effect of Carvedilol Vs Propranolol in Cirrhotic Patients With Variceal Bleeding

Who this might be right for
Liver CirrhosisEsophageal and Gastric VaricesHemorrhage
Shanghai Zhongshan Hospital 480
Not applicableUnknownNCT03277651
What this trial is testing

Noninvasive Diagnostic Platform for Liver Fibrosis and Portal Hypertension

Who this might be right for
Liver FibrosisCirrhosisPortal Hypertension
Shanghai Zhongshan Hospital 200
Not applicableNot Yet RecruitingNCT07087041
What this trial is testing

Predict Recompensation in Patients With Decompensated Cirrhosis Using Spleen Stiffness and Simple Blood Tests

Who this might be right for
Decompensated CirrhosisHepatitis B Virus (HBV) InfectionMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)+3 more
Beijing Friendship Hospital 735
Not applicableActive Not RecruitingNCT03973372
What this trial is testing

ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement

Who this might be right for
Cirrhosis, LiverTransjugular Intrahepatic Portosystemic Shunt (TIPS)
University of Texas Southwestern Medical Center 852
Not applicableLooking for participantsNCT07108075
What this trial is testing

Acute Portal Pressure Reduction by Metformin and Carvedilol Compared to Carvedilol Alone in Cirrhosis.

Who this might be right for
Liver Cirrhosis
Institute of Liver and Biliary Sciences, India 72
Not applicableEnded earlyNCT01079091
What this trial is testing

Hepa Wash Treatment of Patients With Acute-on-Chronic Liver Failure in Intensive Care Units

Who this might be right for
Acute on Chronic Hepatic Failure
Hepa Wash GmbH 14
Not applicableEnded earlyNCT03352882
What this trial is testing

Impact of Transjugular Intrahepatic Portosystemic Shunts on Liver Stiffness

Who this might be right for
Portal HypertensionLiver Fibroses
University of Pennsylvania 1
Large-scale testing (Phase 3)Study completedNCT05563389
What this trial is testing

Statin Impact on Hepatic Decompensation

Who this might be right for
Quality of Lifethe Incidence of Whole Complications Resultant From Decompensated Liver
Tanta University 100
Not applicableUnknownNCT04615091
What this trial is testing

Non-invasive Methods and Surgical Risk Stratification in Cirrhotics Undergoing Elective Extrahepatic Surgery

Who this might be right for
Advanced Chronic Liver DiseaseSurgery--Complications
Azienda Ospedaliera Universitaria Integrata Verona 250
Testing effectiveness (Phase 2)Study completedNCT00004796
What this trial is testing

Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis

Who this might be right for
Portal HypertensionHepatic EncephalopathyCirrhosis
National Center for Research Resources (NCRR) 16
Next Page